Clinical Trial Update: Memory and Antioxidants in Vascular Impairment Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating memory and antioxidants in vascular cognitive impairment without dementia has completed. Results were posted on 2025-03-26.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Cognitive Impairment Without Dementia

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Vascular Cognitive Impairment no Dementia | Phase 2 | Status: COMPLETED | Results posted: 2025-03-26